World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
98
Citations
52554
World Ranking
770
National Ranking
438

Medicine

D-Index
98
Citations
52557
World Ranking
8757
National Ranking
4516

Luc Van Kaer publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Luc Van Kaer sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 328 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Luc Van Kaer D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Luc Van Kaer sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 98 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Luc Van Kaer is affiliated with Vanderbilt University Medical Center in the United States. Their research primarily spans the fields of Immunology and Microbiology as well as Medicine, with a significant focus on Immunology as a subfield. Other subfields of study include Epidemiology, Molecular Biology, Physiology, and Oncology.

The scientist's research topics cover a range of areas related to immune system function and regulation. These include:

  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Autophagy in Disease and Therapy
  • IL-33, ST2, and ILC Pathways
  • Phagocytosis and Immune Regulation
  • Dermatology and Skin Diseases
  • Immunotherapy and Immune Responses

Van Kaer's recent published papers are as follows:

  • Neuroblast senescence in the aged brain augments natural killer cell cytotoxicity leading to impaired neurogenesis and cognition, 2020, Nature Neuroscience
  • Autophagy-related protein PIK3C3/VPS34 controls T cell metabolism and function, 2020, Autophagy
  • NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer, 2023, Cancer Discovery
  • Understanding ER+ Breast Cancer Dormancy Using Bioinspired Synthetic Matrices for Long-Term 3D Culture and Insights into Late Recurrence, 2020, Advanced Biosystems
  • Innate and Innate-like Effector Lymphocytes in Health and Disease, 2022, The Journal of Immunology

Frequent co-authors in Van Kaer's publications include Lan Wu, Seokmann Hong, Hyun Jung Park, Sung Won Lee, and Guan Yang.

The scientist has contributed to the following publication venues multiple times:

  • The Journal of Immunology (8 publications)
  • Frontiers in Immunology (8 publications)
  • International Journal of Molecular Sciences (6 publications)
  • Autophagy (4 publications)
  • Proceedings of the National Academy of Sciences (3 publications)

Van Kaer has also authored a book titled Therapeutic Potential of Innate and Innate-like Effector Lymphocytes in Autoimmune and Inflammatory Diseases, published in 2023 by Frontiers Media.

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

    Daniel J. Klionsky;Amal Kamal Abdel-Aziz;Sara Abdelfatah;Mahmoud Abdellatif

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • NKT cells: what's in a name?

    Dale I Godfrey;H Robson MacDonald;Mitchell Kronenberg;Mark J Smyth

  • The Natural Killer T (NKT) Cell Ligand α-Galactosylceramide Demonstrates Its Immunopotentiating Effect by Inducing Interleukin (IL)-12 Production by Dendritic Cells and IL-12 Receptor Expression on NKT Cells

    Hidemitsu Kitamura;Kenji Iwakabe;Takashi Yahata;Shin-ichiro Nishimura

  • Evidence for a differential avidity model of T cell selection in the thymus

    Philip G. Ashton-Rickardt;Antonio Bandeira;Joseph R. Delaney;Luc Van Kaer

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells.

    Luc Van Kaer;Luc Van Kaer;Philip G. Ashton-Rickardt;Philip G. Ashton-Rickardt;Hidde L. Ploegh;Susumu Tonegawa;Susumu Tonegawa

  • The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice.

    Seokmann Hong;Michael T. Wilson;Isao Serizawa;Lan Wu

  • CD1d1 Mutant Mice Are Deficient in Natural T Cells That PromptlyProduce IL-4

    Sanjeev K Mendiratta;W.David Martin;Seokmann Hong;Alina Boesteanu

  • Critical contribution of liver natural killer T cells to a murine model of hepatitis.

    Kazuyoshi Takeda;Yoshihiro Hayakawa;Luc Van Kaer;Hironori Matsuda

  • Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits.

    Thomas A. Griffin;Dipankar Nandi;Miguel Cruz;Hans Jörg Fehling

  • Glycolipid antigen induces long-term natural killer T cell anergy in mice

    Vrajesh V. Parekh;Michael T. Wilson;Danyvid Olivares-Villagómez;Avneesh K. Singh

  • Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis.

    Avneesh K. Singh;Michael T. Wilson;Seokmann Hong;Danyvid Olivares-Villagómez

  • Organ-specific features of natural killer cells

    Fu-Dong Shi;Fu-Dong Shi;Hans-Gustaf Ljunggren;Antonio La Cava;Luc Van Kaer

  • Cutting Edge: Activation of NK T Cells by CD1d and α-Galactosylceramide Directs Conventional T Cells to the Acquisition of a Th2 Phenotype

    Nagendra Singh;Seokmann Hong;David C. Scherer;David C. Scherer;Isao Serizawa

  • Natural Killer T Cell Ligand α-Galactosylceramide Enhances Protective Immunity Induced by Malaria Vaccines

    Gloria Gonzalez-Aseguinolaza;Luc Van Kaer;Cornelia C. Bergmann;James M. Wilson

  • The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion.

    Michael T. Wilson;Cecilia Johansson;Danyvid Olivares-Villagómez;Avneesh K. Singh

  • alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles.

    Luc Van Kaer

  • H2-M Mutant Mice Are Defective in the Peptide Loading of Class II Molecules, Antigen Presentation, and T Cell Repertoire Selection

    W.David Martin;Geoffrey G Hicks;Sanjeev K Mendiratta;Hitesh I Leva

  • Peptide contributes to the specificity of positive selection of CD8+ T cells in the thymus

    Philip G. Ashton-Rickardt;Luc Van Kaer;Ton N.M. Schumacher;Hidde L. Ploegh

  • Erratum: Organ-specific features of natural killer cells

    Fu-Dong Shi;Hans-Gustaf Ljunggren;Antonio La Cava;Luc Van Kaer

Frequent Co-Authors

Sebastian Joyce
Sebastian Joyce Vanderbilt University Medical Center
Fu-Dong Shi
Fu-Dong Shi Tianjin Medical University General Hospital
Ko Okumura
Ko Okumura Juntendo University
Antonio La Cava
Antonio La Cava University of California, Los Angeles
Hans-Gustaf Ljunggren
Hans-Gustaf Ljunggren Karolinska Institute
Hideo Yagita
Hideo Yagita Juntendo University
Hidde L. Ploegh
Hidde L. Ploegh Boston Children's Hospital
Yasuhiko Koezuka
Yasuhiko Koezuka Vanderbilt University
Keith T. Wilson
Keith T. Wilson Vanderbilt University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology and related healthcare fields, pursuing nursing degrees and certifications offers diverse career pathways. Many students transition from registered nurses to advanced practice roles, such as becoming an Acute Care Nurse Practitioner. Earning the acute care np certification can open specialized clinical opportunities and improve patient outcomes in acute and critical care settings.

Accelerated pathways make advanced nursing education more accessible. Programs like accelerated rn to np programs are designed to fast-track the transition from registered nurse to nurse practitioner, enabling graduates to enter the workforce quickly with advanced skills and credentials.

For those new to nursing, high-quality bachelor's degree options are essential. The best online bsn programs for non nurses offer flexible learning paths that accommodate students without previous healthcare backgrounds, allowing them to gain foundational nursing knowledge that complements immunology expertise.

Additionally, accelerated programs like absn programs with high acceptance rates provide more inclusive admissions, helping a broader range of students pursue nursing careers efficiently while building a strong base for immunology-related professions.

Best Scientists Citing Luc Van Kaer

Trending Scientists

Recently Published Articles